270604 NIMH panel on HIV/AIDS research funding: Process and priorities

Monday, October 29, 2012 : 10:30 AM - 10:50 AM

Cynthia Grossman, PhD , Divison of AIDS Research, NIH/NIMH, Bethesda, MD
Susannah Allison, PhD , Divison of AIDS Research, NIH/NIMH, Bethesda, MD
The proposed Special Session will provide an overview of the grant process and scientific priorities of the National Institute of Mental Health (NIMH) Division of AIDS Research (DAR). NIMH/DAR programs support research in the area of HIV prevention, care and treatment across the lifespan with an emphasis on behavioral and social science research. The Session will include a presentation of NIMH/DAR funding priorities with an emphasis on HIV prevention, care and treatment research across the lifespan. The second portion of the Session will include a presentation on NIMH funding mechanisms and the grant submission process with an emphasis on training and smaller grant mechanisms. NIMH/DAR Program Staff will conduct the presentations and allow time for questions related to scientific priorities and the grant submission process. The Session will be geared towards junior level investigators and/or investigators new to HIV research.

Learning Areas:
Public health or related research
Social and behavioral sciences

Learning Objectives:
Identify key funding priorities of the Division of AIDS Research at NIMH Describe funding mechanisms available at NIMH Name program staff at NIMH with whom to discuss research proposal ideas

Keywords: Research Agenda, Behavioral Research

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Program Officer at the NIMH Division of AIDS and responsible for research grants in the area of Engagement in HIV Care and Secondary Prevention of HIV Transmission. In addition, I have published in the area of HIV prevention among Men who have Sex with Men, Mental Health and HIV and Secondary HIV Prevention.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.